Medtronic Q3 FY26: where the revenue came from and where it went
The whole income statement of Medtronic for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 25, 2025 – Jan 23, 2026
- Reported
- Feb 24, 2026
Revenue$9.02B
+9% year over year
Gross profit$5.76B
64% margin
Operating profit$1.46B
16% margin
Net profit$1.14B
13% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 9.02 | 100% | +9% |
| Cardiovascular | 3.46 | 38% | +14% |
| Neuroscience group | 2.56 | 29% | +4% |
| Medical surgical | 2.17 | 24% | +5% |
| Diabetes group | 0.80 | 9% | +15% |
| All other | 0.03 | 0% | +0% |
| Cost of revenue | −3.26 | 36% | |
| Gross profit | 5.76 | 64% margin | −3pp |
| SG&A | −2.96 | 33% | +0pp |
| Other | −1.34 | 15% | +0pp |
| Operating profit | 1.46 | 16% margin | −4pp |
| Interest & other costs | −0.07 | ||
| Tax | −0.25 | ||
| Net profit | 1.14 | 13% margin | −3pp |
11 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest